Stefanoff P, Kiliszek M, Friedman A
Studenckie Koło Naukowe przy Klinice Neurologicznej CSK A.M. w Warszawie.
Neurol Neurochir Pol. 2000 Jan-Feb;34(1):61-70.
During the last 5 years, 75 patients with focal dystonias were longitudinally treated with injections of botulinum toxin A. Each patient received 2-6 injections. The improvement was assessed after each injection and estimated as significant after 68.47% of injections, as mediocre after 23.42% of injections and none after 8.11% of the injections. The most significant improvement was obtained in patients with blepharospasm and hemifacial spasm, the worst effect was obtained in spasmodic torticollis. Varying responses were observed following repeated injections of botulinum toxin, the clinically assessed improvement did not decrease after successively applied doses. Side-effects occurred after 18% of the injections and were mostly mild and disappeared after short time. This study confirms the usefulness of botulinum toxin, which is an effective and safe treatment of focal dystonias.
在过去5年中,75例局限性肌张力障碍患者接受了肉毒杆菌毒素A注射的纵向治疗。每位患者接受2至6次注射。每次注射后评估改善情况,68.47%的注射后改善显著,23.42%的注射后改善一般,8.11%的注射后无改善。睑痉挛和半面痉挛患者改善最为显著,痉挛性斜颈患者效果最差。重复注射肉毒杆菌毒素后观察到不同的反应,连续给药后临床评估的改善并未降低。18%的注射后出现副作用,大多轻微且短时间后消失。本研究证实了肉毒杆菌毒素的有效性,它是治疗局限性肌张力障碍的一种有效且安全的方法。